EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response

Hao Zhang, Li Fu, Xinwen Leiliang, Chunrun Qu, Wantao Wu, Rong Wen, Ning Huang iD, Qiuguang He, Quan Cheng iD, Guodong Liu, Yuan Cheng

Cancer Communications · 2024-10 · 44 (10) · 1130-1167

DOI: 10.1002/cac2.12597 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Communications, 2024-08. Verfasst von Hao Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, P. R. China. Hauptthemen laut MEDLINE: Neoplasms, Carcinogenesis, Gastrointestinal Microbiome. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 329 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Hunan Provincial Natural Science Foundation of China, Hunan Youth Science and Technology Talent Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The intratumoral microbiome (TM) refers to the microorganisms in the tumor tissues, including bacteria, fungi, viruses, and so on, and is distinct from the gut microbiome and circulating microbiota. TM is strongly associated with tumorigenesis, progression, metastasis, and response to therapy. This paper highlights the current status of TM. Tract sources, adjacent normal tissue, circulatory system, and concomitant tumor co‐metastasis are the main origin of TM. The advanced techniques in TM analysis are comprehensively summarized. Besides, TM is involved in tumor progression through several mechanisms, including DNA damage, activation of oncogenic signaling pathways (phosphoinositide 3‐kinase [PI3K], signal transducer and activator of transcription [STAT], WNT/β‐catenin, and extracellular regulated protein kinases [ERK]), influence of cytokines and induce inflammatory responses, and interaction with the tumor microenvironment (anti‐tumor immunity, pro‐tumor immunity, and microbial‐derived metabolites). Moreover, promising directions of TM in tumor therapy include immunotherapy, chemotherapy, radiotherapy, the application of probiotics/prebiotics/synbiotics, fecal microbiome transplantation, engineered microbiota, phage therapy, and oncolytic virus therapy. The inherent challenges of clinical application are also summarized. This review provides a comprehensive landscape for analyzing TM, especially the TM‐related mechanisms and TM‐based treatment in cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsCarcinogenesisGastrointestinal MicrobiomeHumansTumor MicroenvironmentMicrobiotaAnimals

Stichwörter der Autor:innen

analysis methodsimmunotherapyintratumoral microbiometreatment applicationtumor‐promotive and tumor‐suppressive mechanisms

Autor:innen und Institutionen

  • Department of Neurosurgery, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, P. R. China.
  • Department of Gastroenterology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, P. R. China.
  • Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
  • National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.
  • Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China.

ORCID-Profile: Ning Huang, Quan Cheng

Förderung

  • National Natural Science Foundation of China
  • Hunan Provincial Natural Science Foundation of China
  • Hunan Youth Science and Technology Talent Project
  • China Postdoctoral Science Foundation
  • Chongqing Postdoctoral Science Foundation
  • Kuanren Talents Program of the second affiliated hospital of Chongqing Medical University
  • Chongqing Postdoctoral Research Special Funding Project

Zitieren

APA

Zhang, H., Fu, L., Leiliang, X., Qu, C., Wu, W., Wen, R., Huang, N., He, Q., Cheng, Q., Liu, G., & Cheng, Y. (2024). Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response. Cancer Communications, 44(10), 1130-1167. https://doi.org/10.1002/cac2.12597

Vancouver

Zhang H, Fu L, Leiliang X, Qu C, Wu W, Wen R, et al. Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response. Cancer Communications. 2024;44(10):1130-1167. doi:10.1002/cac2.12597

BibTeX
@article{Zhang2024,
  author = {Zhang, Hao and Fu, Li and Leiliang, Xinwen and Qu, Chunrun and Wu, Wantao and Wen, Rong and Huang, Ning and He, Qiuguang and Cheng, Quan and Liu, Guodong and Cheng, Yuan},
  title = {Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response},
  journal = {Cancer Communications},
  year = {2024},
  volume = {44},
  number = {10},
  pages = {1130--1167},
  doi = {10.1002/cac2.12597}
}
Kostenlos starten →